Blog
Mapping the Next Frontier of Immunotherapy: QSIT Expands Its Scientific Intelligence Program
Truway Health has expanded the scientific-intelligence framework supporting the Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study, identified as TWH-QSIT-IMMUNENET-2025-01 and NCT07221565.
The July 19, 2026 PubMed Intelligence Sweep broadens the study’s continuous monitoring across immunology, cellular metabolism, genetic engineering, cancer genomics, pharmacokinetics, pharmacovigilance, and international research governance.
Connecting Immune Signaling, Energy, and Geno
…
Jul 19th 2026
Truway Health Advances Long COVID Research with GenBank Submission Linked to NCBI BioProject PRJNA1476232
FOR IMMEDIATE RELEASE ONLY
June 10, 2026
Truway Health, Inc. announced the submission of genomic sequence records to the National Center for Biotechnology Information (NCBI) GenBank database under Submission SUB16248244, representing a significant advancement in the company's Long COVID host genomics research program.
The submission is linked to the previously established BioProject PRJNA1476232, entitled Truway Health Long COVID Cohort Host Genomics Study, and integrates accessioned BioSample a
…
Jun 10th 2026